isoniazid has been researched along with beta-lactams in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hori, S | 1 |
Chang, KC; Leung, CC; Tam, CM; Yew, WW | 1 |
Arthur, M; Ballell, L; Barros, D; Cuinet, G; Dhar, N; Dubée, V; Hugonnet, JE; McKinney, JD; Signorino-Gelo, F | 1 |
Nie, Y; Qin, X; Wu, XL; Zhang, K | 1 |
2 review(s) available for isoniazid and beta-lactams
Article | Year |
---|---|
[Adverse effects and safety of antimicrobial agents-neurotoxicities].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Drug Interactions; Humans; Isoniazid; Neuromuscular Junction Diseases; Peripheral Nervous System Diseases; Quinolones; Tetracyclines | 2007 |
WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.
Topics: Acetamides; Adult; Antitubercular Agents; beta-Lactams; Clofazimine; Cohort Studies; Databases, Bibliographic; Female; Fluoroquinolones; Humans; Isoniazid; Linezolid; Macrolides; Male; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2013 |
2 other study(ies) available for isoniazid and beta-lactams
Article | Year |
---|---|
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic.
Topics: Antitubercular Agents; beta-Lactams; Isoniazid; Mycobacterium tuberculosis; Peptidyl Transferases | 2015 |
The Roles of the Two-Component System, MtrAB, in Response to Diverse Cell Envelope Stresses in
Topics: Actinobacteria; Actinomycetales; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cell Wall; Ethambutol; Gene Expression Regulation, Bacterial; Isoniazid; Muramidase; Peptidoglycan | 2022 |